Equity

Boston Scientific·Balance Sheet Statement·8 metrics

Breakdown

Loading...

Metrics

Accumulated other comprehensive income (loss)

Additional paid-in capital

Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding

Treasury Stock, Value

Retained earnings

Total liabilities and stockholders' equity

Total stockholders' equity